期刊
CLINICAL CHEMISTRY AND LABORATORY MEDICINE
卷 58, 期 11, 页码 E267-E269出版社
WALTER DE GRUYTER GMBH
DOI: 10.1515/cclm-2020-0460
关键词
burosumab; FGF23; interference; immunoassay; X-linked hypophosphataemia (XLH)